• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面修饰纳米多孔硅颗粒的细胞相互作用。

Cellular interactions of surface modified nanoporous silicon particles.

机构信息

Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Finland.

出版信息

Nanoscale. 2012 May 21;4(10):3184-92. doi: 10.1039/c2nr30397c. Epub 2012 Apr 16.

DOI:10.1039/c2nr30397c
PMID:22508528
Abstract

In this study, the self-assembly of hydrophobin class II (HFBII) on the surface of thermally hydrocarbonized porous silicon (THCPSi) nanoparticles was investigated. The HFBII-coating converted the hydrophobic particles into more hydrophilic ones, improved the particles' cell viability in both HT-29 and Caco-2 cell lines compared to uncoated particles, and enhanced the particles' cellular association. The amount of HFBII adsorbed onto the particles was also successfully quantified by both the BCA assay and a HPLC method. Importantly, the permeation of a poorly water-soluble drug, indomethacin, loaded into THCPSi particles across Caco-2 monolayers was not affected by the protein coating. In addition, (125)I-radiolabelled HFBII did not extensively permeate the Caco-2 monolayer and was found to be stably adsorbed onto the THCPSi nanoparticles incubated in pH 7.4, which renders the particles the possibility for further track-imaging applications. The results highlight the potential of HFBII coating for improving wettability, increasing biocompatibility and possible intestinal association of PSi nanoparticulates for drug delivery applications.

摘要

本研究考察了亲脂性Ⅱ类(HFBⅡ)在热烃化多孔硅(THCPSi)纳米粒子表面的自组装。与未涂层的粒子相比,HFBⅡ涂层将疏水性粒子转化为亲水性粒子,提高了粒子在 HT-29 和 Caco-2 细胞系中的细胞存活率,并增强了粒子的细胞结合能力。通过 BCA 分析和 HPLC 方法都成功地定量了吸附到粒子上的 HFBⅡ的量。重要的是,负载到 THCPSi 粒子中的疏水性差的药物吲哚美辛的渗透穿过 Caco-2 单层并没有受到蛋白质涂层的影响。此外,(125)I 放射性标记的 HFBⅡ没有广泛渗透到 Caco-2 单层中,并且发现在 pH 7.4 下孵育的 THCPSi 纳米粒子上被稳定吸附,这使得粒子有可能用于进一步的跟踪成像应用。研究结果强调了 HFBⅡ涂层在改善润湿性、提高生物相容性和可能的肠道结合方面的潜力,这对于药物传递应用来说是非常有意义的。

相似文献

1
Cellular interactions of surface modified nanoporous silicon particles.表面修饰纳米多孔硅颗粒的细胞相互作用。
Nanoscale. 2012 May 21;4(10):3184-92. doi: 10.1039/c2nr30397c. Epub 2012 Apr 16.
2
Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles.功能化疏水性蛋白涂层的热碳化多孔硅微球。
Biomaterials. 2011 Dec;32(34):9089-99. doi: 10.1016/j.biomaterials.2011.08.011. Epub 2011 Aug 23.
3
Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution.静脉内递送达泊芬脂质体:稳定性、血浆蛋白吸附和体内分布。
Mol Pharm. 2012 Mar 5;9(3):654-63. doi: 10.1021/mp200611d. Epub 2012 Feb 1.
4
Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.壳聚糖修饰的多孔硅微球增强胰岛素跨肠细胞单层的渗透性。
Biomaterials. 2014 Aug;35(25):7172-9. doi: 10.1016/j.biomaterials.2014.04.104. Epub 2014 May 17.
5
Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats.热碳化多孔硅纳米粒子的生物相容性及其在大鼠体内的分布。
ACS Nano. 2010 Jun 22;4(6):3023-32. doi: 10.1021/nn901657w.
6
In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications.用于伤口愈合应用的生物聚合物修饰多孔硅微粒的体外评估
Eur J Pharm Biopharm. 2014 Nov;88(3):635-42. doi: 10.1016/j.ejpb.2014.09.010. Epub 2014 Oct 8.
7
The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems.具有疏水蛋白涂层的多孔硅纳米粒子口服药物传递系统的粘膜黏附性和胃滞留性。
Biomaterials. 2012 Apr;33(11):3353-62. doi: 10.1016/j.biomaterials.2012.01.029. Epub 2012 Jan 29.
8
Drug permeation across intestinal epithelial cells using porous silicon nanoparticles.多孔硅纳米粒子穿过肠上皮细胞的药物渗透。
Biomaterials. 2011 Apr;32(10):2625-33. doi: 10.1016/j.biomaterials.2010.12.011. Epub 2010 Dec 30.
9
New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles.新时代,乙硫异烟胺的新趋势:载药热碳化多孔硅微球的体外评价。
Eur J Pharm Biopharm. 2012 Jun;81(2):314-23. doi: 10.1016/j.ejpb.2012.02.017. Epub 2012 Mar 6.
10
Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.表面化学和孔径会影响介孔硅微粒的载体性质。
Int J Pharm. 2007 Oct 1;343(1-2):141-7. doi: 10.1016/j.ijpharm.2007.05.010. Epub 2007 May 16.

引用本文的文献

1
Crystallisation Behaviour of Pharmaceutical Compounds Confined within Mesoporous Silicon.限制在介孔硅中的药物化合物的结晶行为
Pharmaceutics. 2020 Mar 2;12(3):214. doi: 10.3390/pharmaceutics12030214.
2
Mesoporous Silicon Particles Favor the Induction of Long-Lived Humoral Responses in Mice to a Peptide-Based Vaccine.介孔硅颗粒有助于在小鼠体内诱导对基于肽的疫苗产生长效体液免疫反应。
Materials (Basel). 2018 Jun 26;11(7):1083. doi: 10.3390/ma11071083.
3
Fungal Hydrophobin Proteins Produce Self-Assembling Protein Films with Diverse Structure and Chemical Stability.
真菌疏水蛋白可产生具有多样结构和化学稳定性的自组装蛋白膜。
Nanomaterials (Basel). 2014 Sep 17;4(3):827-843. doi: 10.3390/nano4030827.
4
Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.用于靶向乳腺癌肿瘤的胺修饰透明质酸功能化多孔硅纳米颗粒。
Nanoscale. 2014 Sep 7;6(17):10377-87. doi: 10.1039/c4nr02187h.
5
Nanostructured porous Si-based nanoparticles for targeted drug delivery.用于靶向药物递送的纳米结构多孔硅基纳米颗粒。
Biomatter. 2012 Oct-Dec;2(4):296-312. doi: 10.4161/biom.22347.